Abstract
Voltage-gated Na (Nav) channels are key regulators of neuronal excitability. The mammalian genome encodes multiple Navs, but reported channel kinetics greatly exceeds gene number. Recent studies have identified a range of post-transcriptional modifications that, combined, are sufficient to generate diversity in channel kinetics and expression level. These mechanisms include RNA-editing, alternative splicing, translational regulation and protein modification. Pharmacological block of Nav is a proven clinical approach to treat human epilepsy, but is now generally accepted to be exhausted for the development of next-generation antiepileptics. The molecular components that mediate post-transcriptional modification may, therefore, provide alternate targets for drug design and recent large-scale screens in Drosophila validate this approach.
Original language | English |
---|---|
Journal | Current Opinion in Physiology |
Early online date | 27 Dec 2017 |
DOIs | |
Publication status | Published - 2018 |
Keywords
- Drosophila
- Pumilio
- Sodium channel
- Splicing
- translation
- Epilepsy